Mirum Pharmaceuticals Quote - MIRM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

47.53

Bid

45.84

Offer

50.30

Volume

435,576

47.40 Day's Range 48.41

23.14 52 Week Range 48.89

Market Cap

2.282B

Previous Close

48.65

Open

48.33

Last Trade

26200

47.6

(average)

Last Trade Time

Financial Volume

US$ 20,864,394

VWAP

47.9007

Average Volume (3m)

424,222

Shares Outstanding

48,004,582

Dividend Yield

PE Ratio

-13.93

Earnings Per Share (EPS)

-3.4

Revenue

186.37M

Net Profit

-163.42M

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Dover, Delaware, USA

Founded

Mirum Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MIRM. The last closing price for Mirum Pharmaceuticals was US$48.65. Over the last year, Mirum Pharmaceuticals shares have traded in a share price range of US$ 23.14 to US$ 48.89.

Mirum Pharmaceuticals currently has 48,004,582 shares in issue. The market capitalisation of Mirum Pharmaceuticals is US$2.34 billion. Mirum Pharmaceuticals has a price to earnings ratio (PE ratio) of -13.93.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates

- 2024 net product sales of approximately $336 million exceeds upper end of guidance range; preliminary and unaudited estimate - 2025 expected global net product sales of $420 million to $435...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.67	3.64151766245	45.86	48.6611	45.26	491323	47.15851644	CS
4	5.8	13.898873712	41.73	48.6611	40.55	447107	44.0757638	CS
12	8.62	22.1536879979	38.91	48.89	38.16	424222	43.37140547	CS
26	7.33	18.2338308458	40.2	48.89	36.2	425546	41.82568916	CS
52	20.78	77.6822429907	26.75	48.89	23.14	509821	34.43459171	CS
156	31.01	187.711864407	16.52	48.89	16.065	450320	28.94086784	CS
260	28.19	145.76008273	19.34	48.89	9.14	316863	27.25784984	CS

MIRM - Frequently Asked Questions (FAQ)

What is the current Mirum Pharmaceuticals share price?

The current share price of Mirum Pharmaceuticals is US$ 47.53

How many Mirum Pharmaceuticals shares are in issue?

Mirum Pharmaceuticals has 48,004,582 shares in issue

What is the market cap of Mirum Pharmaceuticals?

The market capitalisation of Mirum Pharmaceuticals is USD 2.34B

What is the 1 year trading range for Mirum Pharmaceuticals share price?

Mirum Pharmaceuticals has traded in the range of US$ 23.14 to US$ 48.89 during the past year

What is the PE ratio of Mirum Pharmaceuticals?

The price to earnings ratio of Mirum Pharmaceuticals is -13.93

What is the cash to sales ratio of Mirum Pharmaceuticals?

The cash to sales ratio of Mirum Pharmaceuticals is 12.22

What is the reporting currency for Mirum Pharmaceuticals?

Mirum Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Mirum Pharmaceuticals?

The latest annual turnover of Mirum Pharmaceuticals is USD 186.37M

What is the latest annual profit for Mirum Pharmaceuticals?

The latest annual profit of Mirum Pharmaceuticals is USD -163.42M

What is the registered address of Mirum Pharmaceuticals?

The registered address for Mirum Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, DOVER, DELAWARE, 19904

Which industry sector does Mirum Pharmaceuticals operate in?

Mirum Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	US$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	US$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	US$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	US$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	US$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	US$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	US$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90.11 (-38.07%)	8
ACONAclarion Inc	US$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	US$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	US$ 142.62 (-3.12%)	232.88M